false2025-09-3012-31000185512900000100018551292025-01-012025-09-3000018551292024-01-012024-09-3000018551292024-07-012024-09-3000018551292025-07-012025-09-3000018551292024-12-3100018551292025-09-300001855129ifrs-full:RetainedEarningsMember2023-12-310001855129ifrs-full:IssuedCapitalMember2024-12-310001855129ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2023-12-310001855129ifrs-full:OtherReservesMember2024-12-310001855129ifrs-full:IssuedCapitalMember2023-12-310001855129ifrs-full:OtherReservesMember2023-12-3100018551292023-12-310001855129ifrs-full:RetainedEarningsMember2024-12-310001855129ifrs-full:AdditionalPaidinCapitalMember2023-12-310001855129ifrs-full:AdditionalPaidinCapitalMember2024-12-310001855129ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2024-12-310001855129ifrs-full:OtherReservesMember2024-01-012024-09-300001855129ifrs-full:OtherReservesMember2025-01-012025-09-300001855129ifrs-full:AdditionalPaidinCapitalMember2025-01-012025-09-300001855129ifrs-full:RetainedEarningsMember2024-01-012024-09-300001855129ifrs-full:RetainedEarningsMember2025-01-012025-09-300001855129ifrs-full:IssuedCapitalMember2024-01-012024-09-300001855129ifrs-full:IssuedCapitalMember2025-01-012025-09-300001855129ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2025-01-012025-09-300001855129ifrs-full:AdditionalPaidinCapitalMember2024-01-012024-09-300001855129ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2024-01-012024-09-300001855129ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2024-09-300001855129ifrs-full:IssuedCapitalMember2024-09-300001855129ifrs-full:RetainedEarningsMember2025-09-300001855129ifrs-full:AdditionalPaidinCapitalMember2024-09-300001855129ifrs-full:RetainedEarningsMember2024-09-300001855129ifrs-full:OtherReservesMember2024-09-300001855129ifrs-full:IssuedCapitalMember2025-09-300001855129ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2025-09-3000018551292024-09-300001855129ifrs-full:AdditionalPaidinCapitalMember2025-09-300001855129ifrs-full:OtherReservesMember2025-09-300001855129ifrs-full:OrdinarySharesMemberghrs:InitialPublicOfferingMember2025-02-062025-02-060001855129ghrs:InitialPublicOfferingMemberifrs-full:OrdinarySharesMember2025-02-060001855129ghrs:FairValueThroughOtherComprehensiveIncomeMember2024-12-310001855129ghrs:FairValueThroughOtherComprehensiveIncomeMember2025-01-012025-09-300001855129ghrs:FairValueThroughOtherComprehensiveIncomeMember2025-09-300001855129ifrs-full:TopOfRangeMember2025-01-012025-09-300001855129ifrs-full:OrdinarySharesMemberghrs:InitialPublicOfferingMember2025-01-012025-02-060001855129ifrs-full:OrdinarySharesMemberghrs:InitialPublicOfferingMember2024-12-310001855129ghrs:InitialPublicOfferingMemberifrs-full:OrdinarySharesMember2025-01-012025-09-300001855129ghrs:InitialPublicOfferingMemberifrs-full:OrdinarySharesMember2025-09-3000018551292021-06-300001855129ifrs-full:ShareOptionsMember2025-09-300001855129ghrs:ShareOptionExpirationPeriodTwoMember2025-07-012025-09-300001855129ghrs:ShareOptionExpirationPeriodTwoMember2025-01-012025-09-300001855129ghrs:ShareOptionExpirationPeriodThreeMember2025-01-012025-09-300001855129ghrs:ShareOptionExpirationPeriodOneMember2025-01-012025-09-300001855129ghrs:ShareOptionExpirationPeriodThreeMember2025-07-012025-09-3000018551292024-01-012024-12-310001855129ifrs-full:BottomOfRangeMember2025-07-012025-09-300001855129ifrs-full:TopOfRangeMember2025-07-012025-09-300001855129ifrs-full:BottomOfRangeMember2025-01-012025-09-300001855129ifrs-full:ReserveOfSharebasedPaymentsMember2024-12-310001855129ifrs-full:ReserveOfSharebasedPaymentsMember2025-09-300001855129ifrs-full:KeyManagementPersonnelOfEntityOrParentMember2025-01-012025-09-300001855129ifrs-full:KeyManagementPersonnelOfEntityOrParentMember2024-01-012024-09-30iso4217:USDiso4217:USDxbrli:sharesxbrli:sharesxbrli:pureghrs:Segmentutr:Y
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November, 2025.
Commission File Number: 001-40530
GH Research PLC
(Exact name of registrant as specified in its charter)
Joshua Dawson House
Dawson Street
Dublin 2
D02 RY95
Ireland
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
On November 6, 2025, GH Research PLC (the “Company”) reported its third quarter 2025 financial results, provided business updates, and made available an updated investor presentation on its website. A copy of the
press release is exhibited hereto as Exhibit 99.3 and a copy of the investor presentation is attached hereto as Exhibit 99.4.
The fact that this press release and the investor presentation is being made available and furnished herewith should not be deemed an admission as to the materiality of any information contained in the materials.
The information contained in the press release and investor presentation is being provided as of November 6, 2025, and the Company does not undertake any obligation to update the press release or the presentation in the future or to update
forward-looking statements to reflect subsequent actual results.
INCORPORATION BY REFERENCE
This Report on Form 6-K (other than Exhibit 99.3 and Exhibit 99.4 hereto), including Exhibit 99.1 and Exhibit 99.2 hereto, shall be deemed to be incorporated by reference into the registration statement on Form S-8
(Registration Nos. 333-270422 and 333-285311) and the registration statement on Form F-3 (Registration No. 333-285310) of the Company and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents
or reports subsequently filed or furnished.
EXHIBIT INDEX
|
Exhibit No.
|
Description
|
|
99.1
|
Unaudited Condensed Consolidated Interim Financial Statements for the three and nine months ended September 30, 2025
|
|
99.2
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
99.3
|
Press release dated November 6, 2025
|
| 99.4 |
Corporate Presentation for November 2025
|
|
101.INS
|
Inline XBRL Instance Document
|
|
101.SCH
|
Inline XBRL Taxonomy Extension Schema Document
|
|
101.CAL
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document
|
|
101.DEF
|
Inline XBRL Taxonomy Extension Definition Linkbase Document
|
|
101.LAB
|
Inline XBRL Taxonomy Extension Label Linkbase Document
|
|
101.PRE
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
|
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document)
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |
GH Research PLC
|
|
Date: November 6, 2025
|
|
| |
|
| |
By:
|
/s/ Julie Ryan
|
| |
Name:
|
Julie Ryan
|
| |
Title:
|
Vice President, Finance
|
